CIK 0000310158
- Large accelerated filer
Merck & Co., Inc.
Sign in to watch- Ticker
- MRK
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NJ
- Entity type
- Operating
- EIN
- 221918501
- Phone
- +1 908-740-4000
- Business address
- 126 EAST LINCOLN AVENUE, P.O. BOX 2000, RAHWAY, NJ, 07065
- Former names
- Merck & Co. Inc., SCHERING PLOUGH CORP
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $8,611,875
- in 1 filing
Net −$8,611,875. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-05-01 | Williams David Michael EVP,Chief Info&Digital Officer | Exercise or conversion | +560 | $74.50 | $42K | 5,166.76 |
| 2021-05-01 | Williams David Michael EVP,Chief Info&Digital Officer | Shares withheld for taxes | −192 | $74.50 | $14K | 4,974.76 |
| 2021-05-01 | Williams David Michael EVP,Chief Info&Digital Officer | Exercise or conversion · Restricted Stock Unit | −560 | 1,120 | ||
| 2021-05-01 | Karachun Rita A Sr. VP Fince-Global Controller | Exercise or conversion | +901 | $74.50 | $67K | 34,736.97 |
| 2021-05-01 | Karachun Rita A Sr. VP Fince-Global Controller | Shares withheld for taxes | −309 | $74.50 | $23K | 34,427.97 |
| 2021-05-01 | Karachun Rita A Sr. VP Fince-Global Controller | Exercise or conversion · Restricted Stock Unit | −901 | 1,803 | ||
| 2021-03-31 | WENDELL PETER C Director | Grant or award · Phantom Stock | +389.16 | $77.09 | $30K | 100,545.25 |
| 2021-03-31 | Seidman Christine E Director | Grant or award · Phantom Stock | +210.79 | $77.09 | $16K | 3,509.55 |
| 2021-03-31 | Coe Mary Ellen Director | Grant or award · Phantom Stock | +421.59 | $77.09 | $33K | 8,337.19 |
| 2021-03-15 | Mayo Stephen Director | Grant or award · Phantom Stock | +119.9 | $76.23 | $9K | 119.9 |
| 2021-02-26 | Li Dean Y Executive VP & President, MRL | Grant or award | +3,485 | $72.62 | $253K | 10,655.09 |
| 2021-02-26 | Williams David Michael EVP,Chief Info&Digital Officer | Grant or award | +2,090 | $72.62 | $152K | 4,582.88 |
| 2021-02-26 | Karachun Rita A Sr. VP Fince-Global Controller | Grant or award | +6,052 | $72.62 | $439K | 33,835.97 |
| 2021-02-26 | MIZELL STEVEN EVP, Chief HR Officer | Grant or award | +17,830 | $72.62 | $1.3M | 23,181.15 |
| 2021-02-26 | Zachary Jennifer EVP, General Counsel | Grant or award | +24,199 | $72.62 | $1.8M | 30,947.12 |
| 2021-02-26 | Davis Robert M EVP, Global Svcs & CFO | Grant or award | +46,641 | $72.62 | $3.4M | 217,696.76 |
| 2021-02-26 | DeLuca Richard R. EVP&Pres, Merck Animal Heallth | Grant or award | +25,510 | $72.62 | $1.9M | 114,051.69 |
| 2021-02-26 | Gerberding Julie L. EVP Strat Comm, GI Pub Policy | Grant or award | +12,585 | $72.62 | $914K | 39,162.14 |
| 2021-02-26 | Chattopadhyay Sanat Exe V-P & Pres. MMD | Grant or award | +25,772 | $72.62 | $1.9M | 93,145.36 |
| 2021-02-26 | Clyburn Frank EVP, Chief Commercial Officer | Grant or award | +9,432 | $72.62 | $685K | 92,588.77 |
Page 46 of 52 · 1,021 trades